HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Suzuki Selected Research

Vasculitis (Vasculitides)

12/2023Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis.
12/2022Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease.
8/2019Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
1/2019Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Suzuki Research Topics

Disease

39Neoplasms (Cancer)
04/2024 - 03/2004
15Prostatic Neoplasms (Prostate Cancer)
05/2023 - 01/2006
15Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2021 - 01/2006
14Lymphoma (Lymphomas)
08/2019 - 05/2002
11Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2019 - 11/2003
10Neoplasm Metastasis (Metastasis)
02/2020 - 05/2002
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 07/2012
6Poisoning
01/2022 - 03/2016
6Burkitt Lymphoma (Burkitt's Lymphoma)
08/2019 - 01/2006
6Atrial Fibrillation
12/2005 - 02/2003
5Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2019 - 02/2012
4Vasculitis (Vasculitides)
12/2023 - 01/2019
4Hypoxia (Hypoxemia)
01/2019 - 11/2012
4B-Cell Lymphoma (Lymphoma, B Cell)
08/2015 - 01/2006
4Lung Neoplasms (Lung Cancer)
05/2015 - 03/2004
3Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2023 - 01/2019
3Adenocarcinoma
05/2023 - 10/2012
3Inflammation (Inflammations)
12/2022 - 11/2002
3Carcinoma (Carcinomatosis)
11/2022 - 01/2006
3Cysts
01/2020 - 01/2016
3Rectal Neoplasms (Rectal Cancer)
01/2019 - 11/2006
2Hepatocellular Carcinoma (Hepatoma)
04/2024 - 11/2012
2Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2023 - 08/2022
2Glomerulonephritis
12/2022 - 08/2019
2Respiratory Insufficiency (Respiratory Failure)
01/2022 - 01/2022
2Diabetes Mellitus
09/2020 - 01/2005
2Melanoma (Melanoma, Malignant)
04/2020 - 08/2003
2Heart Failure
12/2019 - 01/2011
2Glioma (Gliomas)
06/2019 - 01/2019
2Fibrosis (Cirrhosis)
11/2017 - 09/2013
2Liver Diseases (Liver Disease)
07/2017 - 01/2016
2Periapical Periodontitis (Apical Periodontitis)
01/2017 - 04/2014
2Squamous Cell Carcinoma of Head and Neck
12/2016 - 04/2015
2Fever (Fevers)
08/2016 - 01/2012
2Bone Resorption
10/2015 - 03/2011
2Esophageal Neoplasms (Esophageal Cancer)
12/2014 - 08/2011
2Infections
04/2014 - 01/2004
2Hypersensitivity (Allergy)
04/2014 - 01/2002
2Hypopharyngeal Neoplasms
02/2012 - 10/2010
2Osteoporosis
03/2011 - 08/2009
2Hemorrhage
07/2010 - 08/2008
2Hypertension (High Blood Pressure)
01/2005 - 01/2004

Drug/Important Bio-Agent (IBA)

9N-Acetylneuraminic Acid (Sialic Acid)IBA
08/2019 - 09/2003
8Neuraminidase (Sialidase)IBA
08/2015 - 09/2003
7Polysaccharides (Glycans)IBA
03/2015 - 01/2005
6OligosaccharidesIBA
08/2019 - 11/2003
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2008
5Galectin 1 (LGALS1)IBA
08/2019 - 01/2005
5LectinsIBA
08/2019 - 04/2007
4CollagenIBA
01/2020 - 04/2014
3Apolipoprotein A-II (Apolipoprotein A2)IBA
12/2023 - 01/2019
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2023 - 01/2019
3octacalcium phosphateIBA
12/2021 - 01/2016
3Cisplatin (Platino)FDA LinkGeneric
12/2016 - 03/2015
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2023 - 12/2022
2CytokinesIBA
12/2022 - 01/2019
2AntibodiesIBA
12/2022 - 01/2019
2Therapeutic UsesIBA
12/2022 - 08/2016
2Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2019
2Opioid Analgesics (Opioids)IBA
01/2022 - 01/2022
2Analgesics (Analgesic Drugs)IBA
01/2022 - 01/2022
2Radiation-Sensitizing AgentsIBA
01/2022 - 01/2020
2benzimidazoleIBA
01/2022 - 01/2022
2Illicit Drugs (Recreational Drugs)IBA
01/2022 - 01/2022
2Phosphates (Orthophosphate)IBA
01/2021 - 08/2003
2Oxygen (Dioxygen)IBA
01/2019 - 11/2012
2SteroidsIBA
11/2017 - 01/2012
2Rituximab (Mabthera)FDA Link
11/2017 - 08/2016
2Docetaxel (Taxotere)FDA Link
12/2016 - 04/2015
2Irinotecan (Camptosar)FDA LinkGeneric
11/2016 - 11/2006
2C-Reactive ProteinIBA
01/2016 - 01/2012
2IntegrinsIBA
12/2015 - 10/2015
2Fibronectins (Fibronectin)IBA
12/2015 - 05/2002
2nedaplatinIBA
08/2015 - 03/2015
2Galactose (Galactopyranose)FDA LinkGeneric
02/2012 - 12/2003
2Prostate-Specific Antigen (Semenogelase)IBA
08/2011 - 01/2006
2calcium phosphateIBA
03/2011 - 08/2009
2Liposomes (Liposome)IBA
08/2009 - 08/2003
2Messenger RNA (mRNA)IBA
09/2008 - 05/2002
2CeramidesIBA
09/2008 - 07/2005
2SphingolipidsIBA
10/2006 - 07/2005
2EnzymesIBA
07/2005 - 03/2004
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2005 - 02/2003
2alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
03/2004 - 11/2003
2Disopyramide (Norpace)FDA LinkGeneric
09/2003 - 04/2003
2GlycoconjugatesIBA
09/2003 - 05/2002

Therapy/Procedure

49Radiotherapy
09/2023 - 01/2006
19Therapeutics
01/2024 - 02/2003
14Brachytherapy
05/2021 - 01/2006
6Chemoradiotherapy
07/2020 - 03/2013
6Hysterectomy
08/2015 - 11/2011
5Drug Therapy (Chemotherapy)
03/2024 - 03/2013
5Aftercare (After-Treatment)
11/2017 - 08/2003
5Adjuvant Radiotherapy
03/2013 - 11/2011
4Heavy Ion Radiotherapy
07/2024 - 01/2023
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
07/2022 - 12/2016
3Electric Countershock (Cardioversion)
12/2005 - 09/2003
2Re-Irradiation
06/2019 - 04/2014
2Prostatectomy (Retropubic Prostatectomy)
01/2018 - 08/2011
2Salvage Therapy
11/2016 - 04/2014